Requirements for medications commonly used in the treatment of allergic rhinitis: European Academy of Allergy and Clinical Immunology (EAACI) Allergic Rhinitis and its Impact on Asthma (ARIA)

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 3, 2003, Pages 192-197

  Bousquet, Jean ^a   Van Cauwenberge, Paul ^b   Bachert, Claus ^b   Canonica, Giorgio W ^b   Demoly, Pascal ^b   Durham, Stephen R ^b   Fokkens, Wystske ^b   Lockey, Richard ^b   Meltzer, Eli O ^b   Mullol, Joaquim ^b   Naclerio, Robert M ^b   Price, David ^b   Simons, F Estelle R ^b   Vignola, Antonio M ^b   Warner, John O ^b  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASTEMIZOLE; BECLOMETASONE; CORTICOSTEROID; DECONGESTIVE AGENT; DIPHENHYDRAMINE; GLUCOCORTICOID; SEROTONIN 1 ANTAGONIST; TERFENADINE;

ALLERGIC RHINITIS; APPLE JUICE; CATARACTOGENESIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRY SKIN; EPISTAXIS; FOOD DRUG INTERACTION; GLAUCOMA; GRAPEFRUIT; GROWTH RETARDATION; HUMAN; METABOLIC DISORDER; ORANGE (FRUIT); PRIORITY JOURNAL; REVIEW; SEDATION; SKIN DISEASE; WEIGHT GAIN; XEROSTOMIA;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS; GLUCOCORTICOIDS; HISTAMINE H1 ANTAGONISTS; HUMANS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 0037957304     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2003.00054.x     Document Type: Review

References (44)

1. International Consensus Report on Diagnosis and Management of Rhinitis. International Rhinitis Management Working Group. Allergy 1994;49(19 Suppl):1-34.
2. VAN CAUWENBERGE P, BACHERT C, PASSALACQUA G, BOUSQUET J, CANONICA GW, DURHAM SR et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55(2):116-134.
3. BOUSQUET J, VAN CAUWENBERGE P, KHALTAEV N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl):S147-S334.
4. SIMONS FE, SIMONS KJ. Clinical pharmacology of H1-antihistamines. Clin Allergy Immunol 2002;17:141-178.
5. LEURS R, CHURCH MK, TAGLIALATELA M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 2002;32(4):489-498.
6. BOUSQUET J, LEBEL B, CHANAL I, MOREL A, MICHEL FB. Antiallergic activity of H1-receptor antagonists assessed by nasal challenge. J Allergy Clin Immunol 1988;82(5 Pt 1):881-887.
7. CANONICA GW, CIPRANDI G, PASSALACQUA G. Nonsteroidal antiallergic treatments in allergic rhinitis. Am J Rhinol 2000;14(5):319-323.
8. DOHERTY MM, CHARMAN WN. The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism? Clin Pharmacokinet 2002;41(4):235-253.
9. DRESSER GK, BAILEY DG, LEAKE BF, SCHWARZ UI, DAWSON PA, FREEMAN DJ et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002;71(1):11-20.
10. RENWICK AG. The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes. Clin Exp Allergy 1999;3:116-124.
11. SIMONS FE. H1-antihistamines in children. Clin Allergy Immunol 2002;17:437-464.
12. NAYAK AS, SCHENKEL E. Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis. Allergy 2001;56(11):1077-1080.
13. CIPRANDI G, COSENTINO C, MILANESE M, MONDINO C, CANONICA GW. Fexofenadine reduces nasal congestion in perennial allergic rhinitis. Allergy 2001;56(11):1068-1070.
14. DOLOVICH J, MOOTE DW, MAZZA JA, CLERMONT A, PETITCLERC C, DANZIG M. Efficacy of loratadine versus placebo in the prophylactic treatment of seasonal allergic rhinitis. Ann Allergy 1994;73(3):235-239.
15. CIPRANDI G, BUSCAGLIA S, CATRULLO A, MARCHESI E, BIANCHI B, CANONICA GW. Loratadine in the treatment of cough associated with allergic rhinoconjunctivitis. Ann Allergy Asthma Immunol 1995;75(2):115-120.
16. CIPRANDI G, TOSCA M, RICCA V, PASSALACQUA G, FREGONESE L, EASCE L et al. Cetirizine treatment of allergic cough in children with pollen allergy. Allergy 1997;52(7):752-754.
17. VAN-GANSE E, KAUFMAN L, DERDE MP, YERNAULT JC, DELAUNOIS L, VINCKEN W. Effects of antihistamines in adult asthma: a meta-analysis of clinical trials. Eur Respir J 1997;10(10):2216-2224.
18. GRANT JA, NICODEMUS CF, FINDLAY SR, GLOVSKY MM, GROSSMAN J, KAISER H et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95(5 Pt 1):923-932.
19. CORREN J, HARRIS AG, AARONSON D, BEAUCHER W, BERKOWITZ R, BRONSKY E et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1997;100(6 Pt 1):781-788.
20. WARNER JO. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol 2001;108(6):929-937.
21. PASSALACQUA G, SCORDAMAGLIA A, RUFFONI S, PARODI MN, CANONICA GW. Sedation from H1 antagonists: evaluation methods and experimental results. Allergol Immunopathol Madr 1993;21(2):79-83.
22. WELCH MJ, MELTZER EO, SIMONS FE. H1-antihistamines and the central nervous system. Clin Allergy Immunol 2002;17:337-388.
23. TIMMERMAN H. Why are non-sedating antihistamines non-sedating? Clin Exp Allergy 1999;3:13-18.
24. PASSALACQUA G, BOUSQUET J, BACHERT C, CHURCH MK, BINDSLEY-JENSEN C, NAGY L et al. The clinical safety of H1-receptor antagonists. An EAACI position paper. Allergy 1996;51(10):666-675.
25. BOUSQUET J, VANCAUWENBERGE P, KHALTAEV N. Allergic rhinitis and its impact on asthma (ARIA)- Executive summary. Allergy 2002;57(9):841-855.
26. HOWARTH PH, SALAGEAN M, DOKIC D. Allergic rhinitis: not purely a histamine-related disease. Allergy 2000;55(Suppl 64):7-16.
27. NACLERIO RM. Pathophysiology of perennial allergic rhinitis. Allergy 1997;52(36 Suppl):7-13.
28. BOUSQUET J, CZARLEWSKI W, COUGNARD J, DANZIG M, MICHEL FB. Changes in skin-test reactivity do not correlate with clinical efficacy of H1-blockers in seasonal allergic rhinitis. Allergy 1998;53(6):579-585.
29. CIPRANDI G, PASSALACQUA G, MINCARINI M, RICCA V, CANONICA GW. Continuous versus on demand treatment with cetirizine for allergic rhinitis. Ann Allergy Asthma Immunol 1997;79(6):507-511.
30. CIPRANDI G, TOSCA M, RICCA V, PASSALACQUA G, RICCIO AM, BAGNASCO M et al. Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity. Clin Exp Allergy 1997;27(10):1160-1166.
31. BUSSE WW, MIDDLETON E, STORMS W, DOCKHORN RJ, CHU TJ, GROSSMAN J et al. Corticosteroid-sparing effect of azelastine in the management of bronchial asthma. Am J Respir Crit Care Med 1996;153(1):122-127.
32. FOKKENS WJ, GODTHELP T, HOLM AF, KLEIN-JAN A. Local corticosteroid treatment: the effect on cells and cytokines in nasal allergic inflammation. Am J Rhinol 1998;12(1):21-26.
33. ADCOCK IM, CARAMORI G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 2001;79(4):376-384.
34. JUNIPER EF, GUYATT GH, ARCHER B, FERRIE PJ. Aqueous beclomethasone dipropionate in the treatment of ragweed pollen- induced rhinitis: further exploration of "as needed" use. J Allergy Clin Immunol 1993;92(1 Pt 1):66-72.
35. KASZUBA SM, BAROODY FM, DETINEO M, HANEY L, BLAIR C, NACLERIO RM. Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med 2001;161(21):2581-2587.
36. GRAFT D, AARONSON D, CHERVINSKY P, KAISER H, MELAMED J, PEDINOFF A et al. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. J Allergy Clin Immunol 1996;98(4):724-731.
37. WEINER JM, ABRAMSON MJ, PUY RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. Bmj 1998;317(7173):1624-1629.
38. MINSHALL E, GHAFFAR O, CAMERON L, O'BRIEN F, QUINN H, ROWE-JONES J et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg 1998;118(5):648-654.
39. HOLM AF, FOKKENS WJ, GODTHELP T, MULDER PC, VROOM TM, RIJNTJES E. A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study. Clin Otolaryngol 1998;23(1):69-73.
40. LALIBERTE F, LALIBERTE MF, LECART S, BOUSQUET J, KLOSSEC JM, MOUNEDJI N. Clinical and pathologic methods to assess the long-term safety of nasal corticosteroids. French Triamcinolone Acetonide Study Group. Allergy 2000;55(8):718-722.
41. PERRY RJ, FINDLAY CA, DONALDSON MD. Cushing's syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids. Arch Dis Child 2002;87(1):45-48.
42. SKONER D, RACHELEFSKY G, MELTZER E, CHERVINSKY P, MORRIS R, SELTZER J et al. Detection of growth suppression in children during treatment with intranasal belcomethasone dipropionate. Pediatrics 2000;105:e23.
43. PEDERSEN S. Assessing the effect of intranasal steroids on growth. J Allergy Clin Immunol 2001;108(1 Suppl):S40-S44.
44. ELLEGARD EK, HELLGREN M, KARLSSON NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol 2001;26(5):394-400.